Evidence map›Paper›PMID 36927400›Full record

ArticleBMC public health2023

The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa.

Daihai He, Boqiang Chen, Shi Zhao, Lewi Stone

Open access · goldFull text read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 4 countries.

Daihai HeDepartment of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong, China. daihai.he@polyu.edu.hk.
Boqiang ChenDepartment of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong, China.
Shi ZhaoJC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China.
Lewi StoneMathematical Sciences, School of Science, RMIT University, Melbourne, Australia. lewistone100@gmail.com.
Hong Kong Polytechnic University · HKAustralian Mathematical Sciences Institute · AUCity University of Hong Kong, Shenzhen Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe high immune evasion ability of SARS-COV-2 Omicron variant surprised the world and appears to be far stronger than any previous variant. Previous to Omicron it has been difficult to assess and compare immune evasion ability of different variants, including the Beta and Delta variants, because of the relatively small numbers of reinfections and because of the problems in correctly identifying reinfections in the population. This has led to different claims appearing in the literature. Thus we find claims of both high and low immune evasion for the Beta variant. Some findings have suggested that the Beta variant has a higher immune evasion ability than the Delta variant in South Africa, and others that it has a lower ability.

methodIn this brief report, we re-analyse a unique dataset of variant-specific reinfection data and a simple model to correct for the infection attack rates of different variants.

resultWe find that a model with the Delta variant having  an equal or higher immune evasion ability than Beta variant is compatible with the data.

conclusionWe conclude that the immune evasion ability of Beta variant is not stronger than Delta variant, and indeed, the immune evasion abilities of both variants are weak in South Africa.

Indexed as

COVID-19HumansImmune EvasionReinfectionSARS-CoV-2South AfricaBeta variantDelta variantImmune evasionReinfectionSouth Africa

Identifiers

PMID36927400
PMCPMC10020070
OpenAlexW4327681946

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read8
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.